CHRS Coherus Oncology, Inc.
What the filings say Pressure ▼
Several filing signals but no multi-filing setup yet; see the timeline.
Radar 18 (low attention) · dilution pressure low · listing risk low · governance risk low · runway 9.2 mo · strongest signal: Runway 6–12 months (Jun 30, 2026)
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
18 Radar · attention score (0–100)
24 Dilution pressure · financing + balance sheet
0 Listing risk · exchange standards
0 Governance risk · reporting, auditor, going concern
Analyst note No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Pro on CHRS Alerts One email the morning CHRS files anything that matches your rules (types, minimum score, setups).
12-month history Every signal and setup for CHRS back a year, not just 30 days — see how the current setup built.
Full analyst notes What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV All 985 flagged companies, same-day, sortable and exportable.
Balance sheet (XBRL) $82.9M cash + short-term investments as of Jun 30, 2026
9.2 mo estimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$60.8M stockholders' equity as of Jun 30, 2026
$81.9M public float (10-K cover)
154.5M shares outstanding as of Jul 31, 2026 · was 154.2M Apr 30, 2026
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date Signal Evidence Score Jun 30, 2026 ▼ Runway 6–12 months ~9.2 months runway: liquidity $186,551,000 (cash $82,923,000 + investments $103,628,000) as of 2026-06-30, burn $243,284,667/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing
24
Quiet Alpha Automated SEC-filing intelligence for US microcaps. Updated every weekday morning from SEC EDGAR · last run 2026-08-16.
Newsletter ·
X ·
[email protected] Quiet Alpha is an automated financial research publication. It is not investment advice, not a recommendation to buy or sell any security, and not personalized to any reader. Data are derived from public SEC filings and may contain errors; verify against the source documents linked in each item. Quiet Alpha accepts no compensation from issuers. Microcap securities are illiquid and can lose most or all of their value.